Your session is about to expire
← Back to Search
BC-006 + Meal for Digestive Health (BIO-3003 Trial)
N/A
Waitlist Available
Led By Nicholas A Burd, PhD
Research Sponsored by University of Illinois at Urbana-Champaign
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up five hours postprandial
Awards & highlights
BIO-3003 Trial Summary
This trial is testing a microbial multi-enzyme mixture to see if it has any effect on postprandial nutrient levels, abdominal bloating, flatulence, bowel function, and sleep quality in healthy adults.
Eligible Conditions
- Digestive Health
- Gastrointestinal Health
BIO-3003 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ five hours postprandial
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~five hours postprandial
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Plasma EAA C(MAX)
Plasma EAA time-to-peak
Total plasma essential amino acids (EAA) area under the curve (AUC)
Secondary outcome measures
Abdominal distension/bloating
Appetite
Bloating
+20 moreBIO-3003 Trial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: BC-006Experimental Treatment1 Intervention
Subjects will be directed to consume 1 capsule containing BC-006, twice daily, for 21 days.
Group II: Placebo (Maltodextrin)Placebo Group1 Intervention
Subjects will be directed to consume 1 placebo capsule containing maltodextrin, twice daily, for 21 days.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
BC-006 + Meal
2022
N/A
~30
Find a Location
Who is running the clinical trial?
BIO-CAT Inc.Industry Sponsor
3 Previous Clinical Trials
123 Total Patients Enrolled
1 Trials studying Digestive Health
60 Patients Enrolled for Digestive Health
University of Illinois at Urbana-ChampaignLead Sponsor
189 Previous Clinical Trials
37,355 Total Patients Enrolled
BIO-CAT, Inc.Industry Sponsor
4 Previous Clinical Trials
147 Total Patients Enrolled
2 Trials studying Digestive Health
84 Patients Enrolled for Digestive Health
Media Library
Research Study Groups:
This trial has the following groups:- Group 1: Placebo (Maltodextrin)
- Group 2: BC-006
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger